TENSILON Drug Patent Profile
✉ Email this page to a colleague
When do Tensilon patents expire, and what generic alternatives are available?
Tensilon is a drug marketed by Pai Holdings Pharm and is included in one NDA.
The generic ingredient in TENSILON is edrophonium chloride. There are three drug master file entries for this compound. Additional details are available on the edrophonium chloride profile page.
Summary for TENSILON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,418 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TENSILON at DailyMed |
Recent Clinical Trials for TENSILON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Diego | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for TENSILON
US Patents and Regulatory Information for TENSILON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | TENSILON | edrophonium chloride | INJECTABLE;INJECTION | 007959-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pai Holdings Pharm | TENSILON PRESERVATIVE FREE | edrophonium chloride | INJECTABLE;INJECTION | 007959-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
